URGN ($URGN) Insider Trading & Smart Money Activity

URGN · Biotechnology · Latest filing Oct 8, 2026

$URGN has 8 insider trades on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($430.89K), net -$430.89K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
2
Net insider $ (12 mo)
-$430.89K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

URGN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $350.10K 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 1 · $80.79K 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All URGN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Degnan ChrisChief Financial Officer Sell (Open-market sale) 2.20K sh $80.79K -1.0% —
Insider Wildman Daniel George Buy (Grant or award) 10K sh +3.1%+20.2% Read
Insider Leana Wen Buy (Grant or award) 10K sh +3.1%+20.2% Read
Insider Mark SchoenbergChief Medical Officer Sell (Open-market sale) 10b5-1 10K sh $350.10K +3.1%+20.2% Read
Insider Robinson James JR. Buy (Grant or award) 10K sh +3.1%+20.2% Read
Insider Stuart Holden Buy (Grant or award) 20K sh +3.1%+20.2% Read
Insider Cynthia Butitta Buy (Grant or award) 10K sh +3.1%+20.2% Read
Insider Arie Belldegrun Buy (Grant or award) 20K sh +3.1%+20.2% Read

1W / 1M / 6M = how URGN moved from the trade or filing date.

Insider trading in URGN: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Degnan Chris Chief Financial Officer 1 -$80.79K Oct 8, 2026
Wildman Daniel George 1 — Jun 22, 2026
Leana Wen 1 — Jun 22, 2026
Mark Schoenberg Chief Medical Officer 1 -$350.10K Jun 22, 2026
Robinson James JR. 1 — Jun 22, 2026
Stuart Holden 1 — Jun 22, 2026
Cynthia Butitta 1 — Jun 22, 2026
Arie Belldegrun 1 — Jun 22, 2026

Frequently asked questions

Are URGN insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $430.89K, a net -$430.89K.

What is the latest insider trade in URGN?

Degnan Chris, Chief Financial Officer filed a sell (open-market sale) of 2.20K sh worth $80.79K on Oct 8, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text